173 related articles for article (PubMed ID: 16006997)
21. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
[TBL] [Abstract][Full Text] [Related]
22. [Biomarkers of gentotoxic risk and metabolic polymorphism].
Pavanello S; Clonfero E
Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784
[TBL] [Abstract][Full Text] [Related]
23. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer.
Fan C; Jin M; Chen K; Zhang Y; Zhang S; Liu B
BMC Cancer; 2007 Jun; 7():115. PubMed ID: 17603900
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.
Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N
Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
[TBL] [Abstract][Full Text] [Related]
26. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
Harth V; Schafer M; Abel J; Maintz L; Neuhaus T; Besuden M; Primke R; Wilkesmann A; Thier R; Vetter H; Ko YD; Bruning T; Bolt HM; Ickstadt K
J Toxicol Environ Health A; 2008; 71(13-14):887-97. PubMed ID: 18569591
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to childhood acute lymphoblastic leukemia.
Sinnett D; Krajinovic M; Labuda D
Leuk Lymphoma; 2000 Aug; 38(5-6):447-62. PubMed ID: 10953966
[TBL] [Abstract][Full Text] [Related]
29. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues.
Macé K; Bowman ED; Vautravers P; Shields PG; Harris CC; Pfeifer AM
Eur J Cancer; 1998 May; 34(6):914-20. PubMed ID: 9797707
[TBL] [Abstract][Full Text] [Related]
31. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
Ozawa S
Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
[TBL] [Abstract][Full Text] [Related]
33. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan.
Yeh CC; Sung FC; Tang R; Chang-Chieh CR; Hsieh LL
J Biomed Sci; 2007 Mar; 14(2):183-93. PubMed ID: 17191090
[TBL] [Abstract][Full Text] [Related]
34. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
35. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of the major polymorphic metabolizing enzymes.
Daly AK
Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.
Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022
[TBL] [Abstract][Full Text] [Related]
38. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
39. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
40. Association between polymorphisms of APE1 and OGG1 and risk of colorectal cancer in Taiwan.
Lai CY; Hsieh LL; Tang R; Santella RM; Chang-Chieh CR; Yeh CC
World J Gastroenterol; 2016 Mar; 22(12):3372-80. PubMed ID: 27022219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]